Therefore, in order to further assess the impact of Glipr1 loss on the development of PC malignancies in vivo, future studies should include ageing a larger cohort of our Glipr1-/- mice over a longer timeframe (~ 2 years). Here, GLIPR1 is linked to pachyonychia congenita.